NCT01725620View on ClinicalTrials.gov

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

LBEC0101 (Etanercept 25mg)

DRUG

Enbrel (Etanercept 25mg)

Trial Locations (1)

110-744

Seoul National University Hospital, Clinical Trial Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT01725620 - Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel® | Biotech Hunter | Biotech Hunter